‘Mitotherapy’ for heart failure

Sanchís-Gomar, Fabián; Lippi, Giuseppe; Lucía Mulas, Alejandro

doi:10.1016/j.molmed.2016.02.007

Inicio

‘Mitotherapy’ for heart failure

Sanchís-Gomar, Fabián; Lippi, Giuseppe; Lucía Mulas, Alejandro

Use este identificador para citar o enlazar este ítem: http://hdl.handle.net/11268/5149

Fecha: 2016

Materia UNESCO: Enfermedad cardiovascular
Materia UNESCO: Envejecimiento

Tipo: article

Exportar a:

Resumen:

Abnormalities in mitochondrial dynamics along with those for the molecular mediators involved are presently being viewed with increased interest in the field of cardiovascular disease. Recent research highlights OPA1, a dynamin-like GTPase mediating mitochondrial fusion, as well as the 'mitoproteases' OMA1 and YME1L, as potential therapeutic targets against heart failure.

Mostrar el registro completo del ítem